Founded in 2024, Brecas is a health technology company originating from Tampere University that develops wearable solutions for the continuous monitoring of patients’ vital signs. The company’s technology is based on PaMo (Patient Monitor), a solution developed through research at Tampere University.
PaMo enables continuous monitoring of vital signs without the need for traditional cables or stationary monitoring systems that restrict patient mobility. The technology is designed to support modern healthcare environments by providing reliable patient monitoring while allowing patients greater freedom of movement.
Impact
Brecas’ solution contributes to improved patient safety, particularly in post-operative care and recovery. Continuous monitoring can help healthcare professionals detect potential complications and changes in a patient’s condition at an earlier stage, supporting timely clinical decision-making.
Because the technology does not limit patient mobility, it can also facilitate rehabilitation and recovery. The solution has potential applications across a wide range of healthcare settings where continuous patient monitoring is required.
Background
Brecas is built on research conducted at Tampere University in the fields of physiological measurement, patient monitoring, and health data analysis. The commercialization of the technology was supported through Business Finland’s Research to Business (R2B) funding programme.
Founded in 2024, the company was established to bring the innovative PaMo technology from academic research into practical healthcare use, demonstrating how university-based research can be transformed into solutions that enhance patient care, healthcare efficiency, and clinical outcomes.
Funding source
Business Finland: Research to Business funding